PHARMAS HURT
17/08/22 -"Zantac and Biden seem to have taken the wind from even the strongest pharma groups' sails with the sector being the worst performer last week and down nearly 5% over the last month. So much for a ..."
Pages
50
Language
English
Published on
17/08/22
You may also be interested by these reports :
30/09/22
Our EPS estimate for 2022 and 2023 go down from PLN0.97 to PLN0.43 and PLN1.26 to PLN0.95 as we have lowered our estimates after the weak ...
30/09/22
Allegro Group’s H1 22 were strong on the top line, but weak on the EBIT and net income levels. For the first time, they reflected the results of Mall ...
29/09/22
H&M has published worse-than-expected Q3 22 profitability. The costs inflation and the stronger US dollar have put pressure on the group’s margin ...
28/09/22
There were no surprises in Ferguson’s FY21/22 performance – both organic sales and adjusted operating margin were in-line with market expectations. ...